2025 AAN Annual Meeting

We are excited to attend the 2025 AAN Annual Meeting next week in San Diego, CA. Visit BioSensics booth (#1441) for a demo of our FDA-listed wearable devices, and multi-modal digital health technologies that enable monitoring motor, speech and cognitive function both in clinic and at home. 

In addition, I will be presenting 'Application of Wearable Sensors to Assess Disease Severity in Adults with Charcot-Marie-Tooth Disease'  on Monday, April 7. This work stems from our collaboration with the Hereditary Neuropathy Foundation. You can find the abstract for this presentation here, and our related research page. 

There will also be 6 poster presentations on our work in developing digital health technologies and biomarkers for different neurological disorders:

1. Wearable-based Remote Monitoring of Disease Symptoms in Myasthenia Gravis. See the abstract here, and our related research page. 

2. A Multi-modal Digital Health Technology for Remote Monitoring of Symptoms in Myasthenia Gravis. See the abstract here. 

3. Association Between Wearable Sensor Data and Clinical Scores in Individuals with Early-stage Multiple System Atrophy. See the abstract here, and our related research page. 

4. Remote Monitoring of Physical Activity and Upper Limb Function in Inclusion Body Myositis via Wearable Sensors. See the abstract here and our related research page. 

5. Longitudinal Remote Monitoring of Physical Activity and Falls in Progressive Supranuclear Palsy. See the abstract here and our related research page. 

6. Remote Multi-modal Monitoring in ALS Using Wearable and Digital Assessments. See the abstract here and our related research page.